Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-579,923
Closed -$24.9M 17
2023
Q3
$24.9M Sell
579,923
-1,054,767
-65% -$49.2M 3.95% 12
2023
Q2
$78.1M Sell
1,634,690
-46,681
-3% -$2.25M 12.79% 2
2023
Q1
$81.9M Hold
1,681,371
13.66% 1
2022
Q4
$88.9M Buy
1,681,371
+11,756
+0.7% +$580K 20.06% 1
2022
Q3
$73.1M Buy
1,669,615
+618,931
+59% +$30.6M 19.91% 1
2022
Q2
$52.6M Hold
1,050,684
16.94% 1
2022
Q1
$54.6M Buy
1,050,684
+787,066
+299% +$40.6M 13.45% 2
2021
Q4
$15.6M Buy
+263,618
New +$15.1M 9.43% 4

Other funds holding QGEN

Nekton Capital's QGEN Position: Q4 2023 in Review

Nekton Capital sold out of Qiagen (QGEN) in Q4 2023, closing a stake of 579,923 shares — an estimated $24.9M sold.

Nekton Capital first reported a position in QGEN in Q4 2021 and held it in 8 quarters. The position peaked at $88.9M in Q4 2022. 278 funds tracked by Wall St. Rank hold QGEN as of Q4 2023.

  • Nekton Capital reported no remaining Qiagen position as of Q4 2023 after selling out during the quarter.
  • Nekton Capital sold 579,923 Qiagen shares in Q4 2023, an estimated $24.9M.
  • Nekton Capital first reported a position in Qiagen in Q4 2021 and held it in 8 quarters.
  • Nekton Capital's Qiagen position peaked at $88.9M in Q4 2022.
  • 278 funds tracked by Wall St. Rank held Qiagen as of Q4 2023.

Based on Nekton Capital's 13F filing for Q4 2023, filed 14 Feb 2024.